-
-
-
-
-
-
-
Cosmos Health begins UK sales of veterinary antimicrobial C-ScrubVet
-
-
-
-
-
-
-
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories
-
-
-
-
-
-
-
Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%;
-
-
-
-
-
-
-
Cosmos Health buyback tops $1M with 4.84 million shares repurchased
-
-
-
-
-
-
-
Cosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market Repurchases
-
-
-
-
-
-
-
Cosmos Health buyback tops 4 million shares at roughly $811,000 spent
-
-
-
-
-
-
-
Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases
-
1,189,885 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

